Medicines Australia says it has not heard from companies that they have placed ‘the brake on’ ex-US pricing outcomes in response to the US Most Favored Nation pricing executive order, but added that "this would not be a surprising response." …
Medicines Australia says delayed listings would not be a surprising response
June 10, 2025 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Mark Butler starts the process of NDIS pricing reform
June 11, 2025 - - Latest News -
Pfizer chief sets out the potential implications of 'Most Favored Nation' pricing
June 11, 2025 - - Latest News -
What will the HTA Review Implementation Advisory Group do if the PBAC rejects the process?
June 11, 2025 - - Latest News -
Advocacy group 'pleading' with the NSW Government to establish Men B vaccine program
June 10, 2025 - - Latest News -
New study reveals superior efficacy of cell-based flu vaccine
June 10, 2025 - - Latest News -
Medicines Australia says delayed listings would not be a surprising response
June 10, 2025 - - Latest News -
Companies confirm renewed push for streamlined immunotherapy listing process
June 9, 2025 - - Latest News